Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 145 to 153 of 153 entries
Sorted by: Best Match Show Resources per page
Treatment of Diabetes in People With Heart Failure.

Canadian journal of diabetes

, Connelly KA, Gilbert RE, Liu P.
PMID: 29650096
Can J Diabetes. 2018 Apr;42:S196-S200. doi: 10.1016/j.jcjd.2017.10.026.

No abstract available.

Cite
, Connelly KA, Gilbert RE, et al. Treatment of Diabetes in People With Heart Failure. Can J Diabetes. 2018;42:S196-S200doi: 10.1016/j.jcjd.2017.10.026.
, Connelly, K. A., Gilbert, R. E., & Liu, P. (2018). Treatment of Diabetes in People With Heart Failure. Canadian journal of diabetes, 42S196-S200. https://doi.org/10.1016/j.jcjd.2017.10.026
, et al. "Treatment of Diabetes in People With Heart Failure." Canadian journal of diabetes vol. 42 (2018): S196-S200. doi: https://doi.org/10.1016/j.jcjd.2017.10.026
, Connelly KA, Gilbert RE, Liu P. Treatment of Diabetes in People With Heart Failure. Can J Diabetes. 2018 Apr;42:S196-S200. doi: 10.1016/j.jcjd.2017.10.026. PMID: 29650096.
Copy Download .nbib Format: NLM
Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus.

Endocrinology and metabolism clinics of North America

Jorsal A, Wiggers H, McMurray JJV.
PMID: 29407047
Endocrinol Metab Clin North Am. 2018 Mar;47(1):117-135. doi: 10.1016/j.ecl.2017.10.007. Epub 2017 Dec 08.

This article briefly discusses the epidemiology of heart failure and diabetes and summarizes the key findings from the recent cardiovascular outcome trials in patients with type 2 diabetes, with a focus on heart failure as an endpoint.

Cite
Jorsal A, Wiggers H, McMurray JJV. Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus. Endocrinol Metab Clin North Am. 2017;47(1):117-135doi: 10.1016/j.ecl.2017.10.007.
Jorsal, A., Wiggers, H., & McMurray, J. J. V. (2018). Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus. Endocrinology and metabolism clinics of North America, 47(1), 117-135. https://doi.org/10.1016/j.ecl.2017.10.007
Jorsal, Anders, et al. "Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus." Endocrinology and metabolism clinics of North America vol. 47,1 (2018): 117-135. doi: https://doi.org/10.1016/j.ecl.2017.10.007
Jorsal A, Wiggers H, McMurray JJV. Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus. Endocrinol Metab Clin North Am. 2018 Mar;47(1):117-135. doi: 10.1016/j.ecl.2017.10.007. Epub 2017 Dec 08. PMID: 29407047.
Copy Download .nbib Format: NLM
Using information prescriptions in diabetes.

Nursing times

Rylance A.
PMID: 26285435
Nurs Times. 2015 Mar 4-10;111(10):12-3.

Information prescriptions are designed to give people with diabetes the information they need to understand, engage with and improve on their health targets. The prescriptions are short, personal, easy to read and clinically accurate, and are designed to support...

Cite
Rylance A. Using information prescriptions in diabetes. Nurs Times. 2015;111(10):12-3
Rylance, A. (2015). Using information prescriptions in diabetes. Nursing times, 111(10), 12-3.
Rylance, Amy. "Using information prescriptions in diabetes." Nursing times vol. 111,10 (2015): 12-3.
Rylance A. Using information prescriptions in diabetes. Nurs Times. 2015 Mar 4-10;111(10):12-3. PMID: 26285435.
Copy Download .nbib Format: NLM
Assessing Barriers to Medication Adherence Among Latinos with Diabetes: a Cross-sectional Study.

Journal of general internal medicine

Banuelos Mota A, Feliz Sala EE, Perdomo JM, Solis JA, Solorzano WM, Hochman M, Reilly JM.
PMID: 31161564
J Gen Intern Med. 2020 Feb;35(2):603-605. doi: 10.1007/s11606-019-05041-3. Epub 2019 Jun 03.

No abstract available.

Cite
Banuelos Mota A, Feliz Sala EE, Perdomo JM, et al. Assessing Barriers to Medication Adherence Among Latinos with Diabetes: a Cross-sectional Study. J Gen Intern Med. 2019;35(2):603-605doi: 10.1007/s11606-019-05041-3.
Banuelos Mota, A., Feliz Sala, E. E., Perdomo, J. M., Solis, J. A., Solorzano, W. M., Hochman, M., & Reilly, J. M. (2020). Assessing Barriers to Medication Adherence Among Latinos with Diabetes: a Cross-sectional Study. Journal of general internal medicine, 35(2), 603-605. https://doi.org/10.1007/s11606-019-05041-3
Banuelos Mota, Andrea, et al. "Assessing Barriers to Medication Adherence Among Latinos with Diabetes: a Cross-sectional Study." Journal of general internal medicine vol. 35,2 (2020): 603-605. doi: https://doi.org/10.1007/s11606-019-05041-3
Banuelos Mota A, Feliz Sala EE, Perdomo JM, Solis JA, Solorzano WM, Hochman M, Reilly JM. Assessing Barriers to Medication Adherence Among Latinos with Diabetes: a Cross-sectional Study. J Gen Intern Med. 2020 Feb;35(2):603-605. doi: 10.1007/s11606-019-05041-3. Epub 2019 Jun 03. PMID: 31161564; PMCID: PMC7018941.
Copy Download .nbib Format: NLM
Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors.

International journal of molecular sciences

Dąbrowski M.
PMID: 33562380
Int J Mol Sci. 2021 Feb 07;22(4). doi: 10.3390/ijms22041680.

In the last decade, cancer became the leading cause of death in the population under 65 in the European Union. Diabetes is also considered as a factor increasing risk of cancer incidence and mortality. Type 2 diabetes is frequently...

Cite
Dąbrowski M. Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors. Int J Mol Sci. 2021;22(4)doi: 10.3390/ijms22041680.
Dąbrowski, M. (2021). Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors. International journal of molecular sciences, 22(4), . https://doi.org/10.3390/ijms22041680
Dąbrowski, Mariusz. "Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors." International journal of molecular sciences vol. 22,4 (2021). doi: https://doi.org/10.3390/ijms22041680
Dąbrowski M. Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors. Int J Mol Sci. 2021 Feb 07;22(4). doi: 10.3390/ijms22041680. PMID: 33562380; PMCID: PMC7915237.
Copy Download .nbib Format: NLM
Development of 11beta-HSD1 inhibitors for the treatment of type 2 diabetes.

Mini reviews in medicinal chemistry

Hale C, Wang M.
PMID: 18537725
Mini Rev Med Chem. 2008 Jun;8(7):702-10. doi: 10.2174/138955708784567421.

Glucocorticoid action is linked to the development of obesity and insulin resistance. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) has been proposed as a strategy to suppress glucocorticoid action in a tissue-specific manner. A large variety of 11beta-HSD1 inhibitor...

Cite
Hale C, Wang M. Development of 11beta-HSD1 inhibitors for the treatment of type 2 diabetes. Mini Rev Med Chem. 2008;8(7):702-10doi: 10.2174/138955708784567421.
Hale, C., & Wang, M. (2008). Development of 11beta-HSD1 inhibitors for the treatment of type 2 diabetes. Mini reviews in medicinal chemistry, 8(7), 702-10. https://doi.org/10.2174/138955708784567421
Hale, Clarence, and Wang, Minghan. "Development of 11beta-HSD1 inhibitors for the treatment of type 2 diabetes." Mini reviews in medicinal chemistry vol. 8,7 (2008): 702-10. doi: https://doi.org/10.2174/138955708784567421
Hale C, Wang M. Development of 11beta-HSD1 inhibitors for the treatment of type 2 diabetes. Mini Rev Med Chem. 2008 Jun;8(7):702-10. doi: 10.2174/138955708784567421. PMID: 18537725.
Copy Download .nbib Format: NLM
Simplifying medications for people with type 2 diabetes.

BMJ (Clinical research ed.)

Sluggett JK, Rigby D.
PMID: 34987063
BMJ. 2022 Jan 05;376:n3158. doi: 10.1136/bmj.n3158.

No abstract available.

Cite
Sluggett JK, Rigby D. Simplifying medications for people with type 2 diabetes. BMJ. 2022;376:n3158doi: 10.1136/bmj.n3158.
Sluggett, J. K., & Rigby, D. (2022). Simplifying medications for people with type 2 diabetes. BMJ (Clinical research ed.), 376n3158. https://doi.org/10.1136/bmj.n3158
Sluggett, Janet K, and Rigby, Debbie. "Simplifying medications for people with type 2 diabetes." BMJ (Clinical research ed.) vol. 376 (2022): n3158. doi: https://doi.org/10.1136/bmj.n3158
Sluggett JK, Rigby D. Simplifying medications for people with type 2 diabetes. BMJ. 2022 Jan 05;376:n3158. doi: 10.1136/bmj.n3158. PMID: 34987063.
Copy Download .nbib Format: NLM
Vanita Aroda: the accidental role model… by no accident.

The lancet. Diabetes & endocrinology

Venkatesan P.
PMID: 33971136
Lancet Diabetes Endocrinol. 2021 Aug;9(8):483. doi: 10.1016/S2213-8587(21)00124-8. Epub 2021 May 07.

No abstract available.

Cite
Venkatesan P. Vanita Aroda: the accidental role model… by no accident. Lancet Diabetes Endocrinol. 2021;9(8):483doi: 10.1016/S2213-8587(21)00124-8.
Venkatesan, P. (2021). Vanita Aroda: the accidental role model… by no accident. The lancet. Diabetes & endocrinology, 9(8), 483. https://doi.org/10.1016/S2213-8587(21)00124-8
Venkatesan, Priya. "Vanita Aroda: the accidental role model… by no accident." The lancet. Diabetes & endocrinology vol. 9,8 (2021): 483. doi: https://doi.org/10.1016/S2213-8587(21)00124-8
Venkatesan P. Vanita Aroda: the accidental role model… by no accident. Lancet Diabetes Endocrinol. 2021 Aug;9(8):483. doi: 10.1016/S2213-8587(21)00124-8. Epub 2021 May 07. PMID: 33971136.
Copy Download .nbib Format: NLM
SGLT-2 Inhibitors in Heart Failure: Volume or Value?.

Journal of the American College of Cardiology

Kosiborod MN, Vaduganathan M.
PMID: 33736820
J Am Coll Cardiol. 2021 Mar 23;77(11):1393-1396. doi: 10.1016/j.jacc.2021.02.005.

No abstract available.

Cite
Kosiborod MN, Vaduganathan M. SGLT-2 Inhibitors in Heart Failure: Volume or Value?. J Am Coll Cardiol. 2021;77(11):1393-1396doi: 10.1016/j.jacc.2021.02.005.
Kosiborod, M. N., & Vaduganathan, M. (2021). SGLT-2 Inhibitors in Heart Failure: Volume or Value?. Journal of the American College of Cardiology, 77(11), 1393-1396. https://doi.org/10.1016/j.jacc.2021.02.005
Kosiborod, Mikhail N, and Vaduganathan, Muthiah. "SGLT-2 Inhibitors in Heart Failure: Volume or Value?." Journal of the American College of Cardiology vol. 77,11 (2021): 1393-1396. doi: https://doi.org/10.1016/j.jacc.2021.02.005
Kosiborod MN, Vaduganathan M. SGLT-2 Inhibitors in Heart Failure: Volume or Value?. J Am Coll Cardiol. 2021 Mar 23;77(11):1393-1396. doi: 10.1016/j.jacc.2021.02.005. PMID: 33736820.
Copy Download .nbib Format: NLM
Showing 145 to 153 of 153 entries